Verapamil

Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem

1980 • 865 citations

Verapamil

1978 • 829 citations

Mechanism of Action of Calcium-Channel-Blocking Agents

1982 • 692 citations

Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part II: Hemodynamic Effects and Clinical Applications

1980 • 551 citations

Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium

1980 • 459 citations

Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.

1981 • 401 citations

Hemodynamics of Hypertension

1960 • 373 citations

Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part I: Basic and Clinical Electrophysiologic Effects

1980 • 332 citations

Effects of Agents which Inhibit the Slow Channel on Sinus Node Automaticity and Atrioventricular Conduction in the Dog

1974 • 284 citations

New antiarrhythmic agents

1978 • 279 citations

Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.

1981 • 262 citations

Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies.

1981 • 256 citations

Physiological disposition of verapamil in man

1976 • 244 citations

Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.

1982 • 212 citations

The influence of verapamil on serum digoxin concentration.

1982 • 207 citations

New perspectives in the pharmacologic therapy of cardiac arrhythmias

1980 • 206 citations

Re-Examination of the Hemodynamics of Hypertension

1969 • 205 citations

Management of unstable angina at rest by verapamil. A double-blind cross-over study in coronary care unit.

1979 • 201 citations

Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease

1981 • 198 citations

Differential cardiovascular effects of calcium channel blocking agents: Potential mechanisms

1982 • 195 citations

Effects of intravenous verapamil on hemodynamics in patients with heart disease

1977 • 192 citations

Clinical Pharmacokinetics of Verapamil, Nifedipine and Diltiazem

1986 • 184 citations

Pharmacokinetics of (+)‐, (‐)‐ and (+/‐)‐verapamil after intravenous administration.

1984 • 183 citations

Effects of verapamil on myocardial performance in coronary disease.

1979 • 182 citations

Stereoselective first‐pass metabolism of highly cleared drugs: studies of the bioavailability of L‐ and D‐verapamil examined with a stable isotope technique.

1984 • 177 citations

Digoxin-verapamil interaction

1981 • 177 citations

Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris

1981 • 169 citations

The metabolism of DL-[14C]verapamil in man.

1979 • 167 citations

Factors influencing the hypotensive effects of calcium antagonists.

1983 • 164 citations

Comparison of Cardiovascular, Renal, and Humoral Effects of Acute Administration of Two Calcium Channel Blockers in Normotensive and Hypertensive Subjects

1982 • 164 citations

Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome.

1974 • 150 citations

Cardiac Decompensation Following Verapamil Therapy in Infants with Supraventricular Tachycardia

1985 • 149 citations

Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise.

1982 • 146 citations

The Pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses

1982 • 140 citations

The 24-hour ambulatory blood pressure profile with verapamil.

1982 • 136 citations

Precipitation of Cardiac Arrest by Verapamil in Patients with Wolff-ParkinsonWhite Syndrome

1986 • 133 citations

Effect of diltiazem in patients with variant angina: A randomized double-blind trial

1981 • 133 citations

Combined therapy with verapamil and propranolol in chronic stable angina

1982 • 132 citations

Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: A review

1983 • 132 citations

The treatment of hypertension with verapamil.

1978 • 130 citations

Verapamil Prophylaxis of Migraine

1983 • 129 citations

Hazards of intravenous verapamil for sustained ventricular tachycardia

1987 • 129 citations

Verapamil Pharmacodynamics and Disposition in Young and Elderly Hypertensive Patients

1986 • 127 citations

VERAPAMIL IN CHRONIC STABLE ANGINA

1980 • 124 citations

Clinical Pharmacokinetics of Verapamil

1984 • 124 citations

III. CALCIUM ANTAGONISTS

1980 • 123 citations

Reduced verapamil clearance during long-term oral administration

1981 • 119 citations

Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog

1978 • 119 citations

Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis.

1981 • 118 citations

Effects of d,l-verapamil on atrioventricular conduction in relation to its stereoselective first-pass metabolism

1985 • 118 citations

Action of verapamil on sinus node, atrioventricular, and intraventricular conduction.

1973 • 117 citations

Cardiovascular effects of verapamil in patients with essential hypertension.

1987 • 117 citations

Verapamil disposition kinetics in chronic atrial fibrillation

1981 • 116 citations

Inhibition of Human Platelet Functions by Verapamil

1981 • 114 citations

Verapamil kinetics in normal subjects and patients with coronary artery spasm

1981 • 113 citations

Antihypertensive and renal effects of orally administered verapamil

1980 • 111 citations

Differential effects of systemic and intracoronary calcium channel blocking agents on global and regional left ventricular function in conscious dogs

1981 • 108 citations

Adverse Reactions to Calcium Antagonists

1983 • 108 citations

Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil

1981 • 105 citations

Calcium Antagonists Clinical Use in the Treatment of Arrhythmias

1983 • 104 citations

The place of the calcium antagonist verapamil in antihypertensive therapy.

1982 • 102 citations

Age, race, blood pressure and renin: Predictors for antihypertensive treatment with calcium antagonists

1985 • 100 citations

[BAY a 1040--a highly potent Ca ++ -antagonistic inhibitor of electro-mechanical coupling processes in mammalian myocardium].

1972 • 100 citations

Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease

1984 • 99 citations

Verapamil in prophylactic therapy of migraine

1984 • 98 citations

Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single i.v. and oral administration and during chronic treatment

1980 • 97 citations

Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy

1986 • 94 citations

A Comparison of Verapamil and Propranolol for the Initial Treatment of Hypertension

1986 • 92 citations

Reassessing Portal Venous Pressure Measurements

1984 • 90 citations

Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension

1988 • 89 citations

Verapamil protein binding in patients and in normal subjects

1981 • 88 citations

Verapamil disposition in liver disease and intensive-care patients: Kinetics, clearance, and apparent blood flow relationships

1981 • 87 citations

Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: A placebo-controlled, double-blind, randomized, crossover study

1985 • 87 citations

Antihypertensive and Humoral Effects of Verapamil and Nifedipine in Essential Hypertension

1982 • 86 citations

Superior intensity and reproducibility of SHU-454, a new right heart contrast agent

1984 • 86 citations

Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy

1985 • 85 citations

Effects of Calcium Antagonists on Glucose Homeostasis and Serum Lipids in Non-Diabetic and Diabetic Subjects: A Review

1987 • 84 citations

Klinisch-experimentelle Untersuchungen über die blutdrucksenkende Wirkung von Verapamil

1970 • 76 citations

Effect of isosorbide dinitrate, verapamil, and labetalol on portal pressure in cirrhosis.

1985 • 75 citations

Effects of calcium entry blockers on renin-angiotensin-aldosterone system, renal function and hemodynamics, salt and water excretion and body fluid composition

1985 • 75 citations

Effect of verapamil on normal sinoatrial node function and on sick sinus syndrome

1978 • 75 citations

Does verapamil improve left ventricular relaxation in patients with myocardial hypertrophy?

1986 • 74 citations

Antihypertensive Treatment Using Calcium Antagonists in Combination with Captopril Rather than Diuretics

1985 • 74 citations

Modification of experimental atherosclerosis by calcium-channel blockers

1985 • 72 citations

Pharmacokinetics of verapamil in man.

1979 • 70 citations

Hemodynamic and electrophysiologic effects of verapamil and nifedipine in patients on propranolol

1982 • 69 citations

Antianginal and myocardial metabolic properties of verapamil in coronary artery disease

1980 • 68 citations

The Antihypertensive Effect of Verapamil at Extremes of Dietary Sodium Intake

1987 • 67 citations

Verapamil-Induced Hyperprolactinemia and Galactorrhea

1981 • 67 citations

Hyperkalemia, Verapamil, and Dantrolene

1987 • 66 citations

The Pharmacology of Verapamil. III. Pharmacokinetics in Normal Subjects After Intravenous Drug Administration

1981 • 65 citations

Comparative effects of verapamil and isradipine on steady-state digoxin kinetics

1988 • 64 citations

Calcium Channel Blockers

1988 • 63 citations

Consequences of uncontrolled calcium entry and its prevention with calcium antagonists

1983 • 62 citations

Hemodynamic and myocardial performance characteristics after verapamil use in congestive heart failure

1983 • 62 citations

Acute Intoxication with Verapamil

1979 • 59 citations

Calcium and catecholamines: Relevance to cardiomyopathies and significance in therapeutic strategies

1985 • 58 citations

Immediate Haemodynamic Effects of Verapamil in Man

1975 • 58 citations

Serum Concentration and Antihypertensive Effect of Slow-Release Verapamil

1982 • 58 citations

Effects of verapamil on platelet aggregation, ATP release and thromboxane generation

1983 • 58 citations

Calcium antagonists and the ischemic myocardium

1987 • 57 citations

Treatment of severe verapamil poisoning with combined amrinone-isoproterenol therapy

1986 • 57 citations

Verapamil plasma binding: Relationship to α1-acid glycoprotein and drug efficacy

1983 • 56 citations

Inhibition of human platelet function by verapamil

1982 • 55 citations

Hemodynamic effects of verapamil and practolol in man.

1976 • 55 citations

Verapamil and digoxin: Their respective effects on atrial fibrillation and their interaction

1982 • 55 citations

Verapamil and Norverapamil Plasma Concentrations During Long-Term Therapy in Patients with Hypertrophic Obstructive Cardiomyopathy

1980 • 54 citations

Calcium Antagonists Clinical Use in the Treatment of Angina

1983 • 54 citations

Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris

1982 • 54 citations

Hypotension after Quinidine plus Verapamil

1985 • 54 citations

Mechanism of relief of pacing induced angina with oral verapamil: reduced oxygen demand.

1983 • 53 citations

Calcium entry blockers and myocardial function.

1981 • 53 citations

Comparison of intravenous and oral verapamil dosing

1982 • 53 citations

Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.

1986 • 52 citations

The hemodynamic effect of verapamil on portal hypertension in patients with postnecrotic cirrhosis

1986 • 51 citations

Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.

1985 • 50 citations

Side effects of verapamil in infants.

1983 • 50 citations

Reduction of creatine kinase and creatine kinase-MB indexes of infarct size by intravenous verapamil

1984 • 50 citations

Inter- and intra-subject variation in the first-pass elimination of highly cleared drugs during chronic dosing

1984 • 49 citations

Neurotoxicity Caused by Lithium‐Verapamil Synergism

1986 • 48 citations

Verapamil and propranolol in essential hypertension

1984 • 48 citations

Verapamil and Reversal of Vecuronium Neuromuscular Blockade

1984 • 48 citations

Verapamil pharmacokinetics and apparent hepatic and renal blood flow.

1985 • 48 citations

Near-total Reduction in Verapamil Bioavailability by Rifampin

1988 • 47 citations

The clinical use of verapamil.

1982 • 45 citations

Comparison of verapamil and nifedipine in the treatment of variant angina pectoris: Preliminary observations in 10 patients

1981 • 45 citations

Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome

1982 • 45 citations

The effect of inhaled verapamil on resting bronchial tone and airway contractions induced by histamine and acetylcholine in normal and asthmatic subjects.

1984 • 45 citations

Determination of verapamil in human plasma by mass fragmentography using stable isotope-labelled verapamil as internal standard.

1977 • 45 citations

Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells.

1988 • 45 citations

Comparative effects of propranolol and verapamil alone and in combination on left ventricular function and volumes in patients with chronic exertional angina: a double-blind, placebo-controlled, randomized, crossover study with radionuclide ventriculography.

1983 • 44 citations

Hemodynamic and clinical effects of combined verapamil and propranolol therapy in angina pectoris

1982 • 44 citations

Can the Progression of Coronary Sclerosis Be Influenced by Calcium Antagonists?

1989 • 44 citations

Detrimental effects of verapamil in patients with primary pulmonary hypertension.

1984 • 44 citations

Effects of Verapamil in Hypertensive Patients

1984 • 42 citations

Fatal poisoning with verapamil

1977 • 42 citations

The effect of coadministration of verapamil on the pharmacokinetics and metabolism of quinidine

1987 • 41 citations

Calcium Antagonists. Mechanisms, Therapeutic Indications and Reservations: A Review

1984 • 41 citations

Three cases of severe verapamil poisoning

1981 • 40 citations

Acute verapamil poisoning: Successful treatment with epinephrine

1982 • 39 citations

Pharmacokinetics of verapamil in patients with renal failure

1985 • 39 citations

Liquid-chromatographic quantification compared with gas-chromatographic-mass-spectrometric determination of verapamil and norverapamil in plasma.

1988 • 38 citations

Interaction of verapamil with human platelet alpha-adrenergic receptors

1982 • 38 citations

The Haemodynamic Effects of Nifedipine, Verapamil and Diltiazem in Patients with Coronary Artery Disease

1986 • 37 citations

Effects of verapamil on coronary hemodynamic function and vasomobility relative to its mechanism of antianginal action

1983 • 37 citations

Treating hypertension in black compared with white non-insulin dependent diabetics: a double blind trial of verapamil and metoprolol.

1988 • 37 citations

The effect of inhaled verapamil on allergen‐induced bronchoconstriction

1983 • 37 citations

Clinical Pharmacokinetics of Calcium Channel Antagonists

1982 • 37 citations

Combined alpha adrenoceptor antagonism and calcium channel blockade in normal subjects

1984 • 36 citations

Pharmacokinetics of Calcium Blockers in Patients with Renal Insufficiency and in Geriatric Patients

1984 • 36 citations

Verapamil in acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.

1984 • 35 citations

Antiplatelet effects of verapamil in man

1981 • 34 citations

A Double-Blind Comparison of Verapamil and Labetalol in Hypertensive Patients with Coexisting Chronic Obstructive Airways Disease

1982 • 33 citations

Hydrochlorothiazide Is Not Additive to Verapamil in Treating Essential Hypertension

1989 • 32 citations

Calcium in the pathogenesis and therapy of human hypertension

1985 • 32 citations

Increased quinidine plasma concentrations during administration of verapamil: A new quinidine-verapamil interaction

1986 • 32 citations

Clinical pharmacokinetics of verapamil in patients with atrial fibrillation

1982 • 31 citations

Verapamil: Full spectrum calcium channel blocking agent: An overview

1984 • 31 citations

Calcium antagonists and the second drug for hypertensive therapy

1986 • 31 citations

Verapamil and breast-feeding

1986 • 30 citations

Exercise hemodynamics and oxygen delivery in human hypertension. Response to verapamil.

1986 • 30 citations

Effect of coadministration of verapamil and quinidine on serum digoxin concentration

1983 • 29 citations

Excretion of verapamil in human milk

1983 • 29 citations

An investigation of the cause of accumulation of verapamil during regular dosing in patients.

1985 • 29 citations

Pharmacologic and hemodynamic mechanisms underlying the antianginal actions of verapamil

1982 • 29 citations

Interference of calcium entry blockade in vivo with pressor responses to alpha-adrenergic stimulation: effects of two unrelated blockers on responses to both exogenous and endogenously released norepinephrine.

1984 • 29 citations

Hemodynamic Effects of Verapamil in Essential Hypertension at Rest and During Exercise

1984 • 29 citations

The comparative effects of verapamil and a new dihydropyridine calcium channel blocker on digoxin pharmacokinetics

1987 • 28 citations

Verapamil cardioplegia: Improved myocardial preservation during global ischemia

1984 • 28 citations

Diltiazem and verapamil: Functional antagonism of exogenous noradrenalin and angiotensin II in man

1984 • 28 citations

Beta blockers and verapamil: a cautionary tale.

1984 • 28 citations

The Effects of Slow Channel Blockers and Beta Blockers on Atrioventricular Nodal Conduction

1988 • 28 citations

Noninvasive assessment of the haemodynamic effects of nicardipine in normotensive subjects.

1985 • 27 citations

Verapamil disposition‐effects of sulphinpyrazone and cimetidine.

1985 • 27 citations

Cardiovascular effects of verapamil in essential hypertension

1987 • 27 citations

Liver damage from verapamil.

1984 • 26 citations

Factors affecting the plasma protein binding of verapamil and norverapamil in man.

1980 • 26 citations

Differential effects of calcium channel blocking agents on oxygen consumption rate in vascular smooth muscle

1982 • 26 citations

Comparative Effects of Oral and Inhaled Verapamil on Antigen-Induced Bronchoconstriction

1985 • 25 citations

Pharmacokinetics and pharmacodynamics of two formulations of verapamil.

1987 • 25 citations

Verapamil in the management of chronic hypertension.

1980 • 25 citations

Twice-Daily Administration of Oral Verapamil in the Treatment of Essential Hypertension

1986 • 24 citations

Pharmacological Actions of APP 201-533, a Novel Cardiotonic Agent

1985 • 23 citations

Verapamil-digoxin interaction

1984 • 23 citations

Influence of Oral Verapamil on Glucoregulatory Hormones in Man*

1985 • 23 citations

Kinetics and dynamics of calcium entry antagonists in systemic hypertension

1986 • 23 citations

Verapamil disposition and effect on PQ-intervals after buccal, oral and intravenous administration.

1984 • 22 citations

Measurement of Verapamil Concentrations in Plasma by Gas Chromatography and High Pressure Liquid Chromatography

1980 • 22 citations

Decreased Binding of Verapamil to Plasma Proteins in Patients with Liver Disease

1984 • 22 citations

Verapamil-induced changes in digoxin kinetics and intraerythrocytic sodium concentration

1983 • 22 citations

Decreased serum lithium during verapamil therapy

1984 • 22 citations

Comparison of betaxolol with verapamil in hypertensive patients: discrepancy between office and ambulatory blood pressures

1988 • 22 citations

Inhibition of Platelet Function by Antiarrhythmic Drugs, Verapamil and Disopyramide

1982 • 22 citations

Hepatic Injury Possibly Induced by Verapamil

1983 • 22 citations

Fatal acute intoxication with verapamil.

1983 • 22 citations

Once a day verapamil in essential hypertension.

1986 • 21 citations

Reversal of Cardiac Hypertrophy by Long-Term Treatment with Calcium Antagonists in Hypertensive Patients

1988 • 21 citations

The antihypertensive efficacy of ketanserin in the elderly evaluated by ambulatory blood pressure measurement.

1990 • 21 citations

Effect of cimetidine on verapamil disposition

1985 • 21 citations

Gas-chromatographic determination of verapamil and norverapamil, with a nitrogen-selective detector.

1982 • 21 citations

Comparison of beta-adrenoceptor blockers and calcium antagonists in hypertension.

1983 • 21 citations

Effects of chronic phenobarbital on verapamil disposition in humans.

1988 • 20 citations

Asystole after verapamil and digoxin.

1980 • 20 citations

Verapamil-Rifampin Interaction

1985 • 20 citations

Assessment of ‘once daily’ verapamil for the treatment of hypertension using ambulatory, intra-arterial blood pressure recording

1987 • 20 citations

Antihypertensive Effect of Verapamil in Patients with Newly Discovered Mild to Moderate Essential Hypertension

1984 • 20 citations

Verapamil Hydrochloride: Pharmacological Properties and Role in Cardiovascular Therapeutics

1982 • 20 citations

Sinus arrest caused by atenolol‐verapamil combination

1987 • 19 citations

The effects of verapamil and propranolol on exercise tolerance in hypertensive patients

1987 • 19 citations

VERAPAMIL IN THE LONG–TERM TREATMENT OF ANGINA PECTORIS

1980 • 19 citations

Verapamil and Norverapamil Determination in Human Plasma by Gas-Liquid Chromatography Using Nitrogen-Phosphorus Detection: Application to Single-Dose Pharmacokinetic Studies

1984 • 18 citations

Verapamil and Propranolol: A Comparison of Two Antihypertensive Agents

1984 • 18 citations

No Metabolic Side Effects of Long-Term Treatment with Verapamil in Hypertension

1988 • 18 citations

Effect of verapamil on left ventricular function: A randomized, placebo-controlled study

1983 • 18 citations

Hemodynamic effects of calcium channel blockers at rest and during exercise in essential hypertension

1985 • 18 citations

Verapamil hepatotoxicity: A hypersensitivity reaction

1986 • 18 citations

Impotence During Therapy With Verapamil

1983 • 17 citations

An Evaluation of the Pharmacokinetics, Pharmacodynamics, and Dialyzability of Verapamil in Chronic Hemodialysis Patients

1988 • 17 citations

Effect of verapamil on renal plasma flow, glomerular filtration rate and plasma angiotensin II, aldosterone and arginine vasopressin in essential hypertension

1985 • 17 citations

The effects of verapamil on renal blood flow, renal function, and neurohormonal profiles in patients with moderate to severe hypertension.

1986 • 17 citations

Cerebral Infarction Associated with Oral Verapamil Overdose

1988 • 16 citations

Calcium channel antagonists part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications

1988 • 16 citations

Pharmacokinetics of verapamil in patients with hypertension

1986 • 16 citations

Verapamil in Treatment of Chronic Stable Angina

1983 • 16 citations

The influence of antituberculosis drugs on the plasma level of verapamil

1987 • 15 citations

Extent and pharmacokinetic mechanisms of oral atenolol-verapamil interaction in man

1988 • 15 citations

Effect of calcium channel blockade and beta-adrenoceptor blockade on short graded and single-level endurance exercises in normal men

1988 • 15 citations

Lack of interaction between verapamil and cimetidine

1985 • 15 citations

Comparison of two calcium antagonists, verapamil and gallopamil (D-600), in exercise-induced asthma.

1985 • 14 citations

Poisoning with sustained-release verapamil

1988 • 14 citations

Effects of the calcium channel blocker, verapamil, on asthmatic airway responses to muscarinic, histaminergic, and allergenic stimuli.

1986 • 14 citations

Pharmacokinetics of sustained-release verapamil after a single administration and at steady state

1985 • 13 citations

Verapamil Kinetics during Maintenance Hemodialysis

1985 • 13 citations

Treatment of angina pectoris and hypertension with sustained-release calcium channel-blocking drugs.

1987 • 13 citations

Hypercalcemic and Calcium‐Antagonistic Effects on Insulin Release and Oral Glucose Tolerance in Man

1982 • 13 citations

The calcium‐channel blocker, verapamil, does not improve portal pressure in patients with alcoholic cirrhosis.

1988 • 13 citations

Calcium Antagonists in the Treatment of Hypertension

1988 • 13 citations

Determination of Verapamil and Its Primary Metabolites In Serum by Ion-Pair Adsorption High-Performance Liquid Chromatography

1988 • 13 citations

Verapamil and bendrofluazide in the treatment of hypertension: A controlled study of effectiveness alone and in combination

1988 • 12 citations

The effects on left ventricular performance of nifedipine and verapamil in exercise‐induced angina pectoris.

1984 • 12 citations

Does Verapamil Influence Glucose‐Induced Insulin Release in Man?

1981 • 12 citations

[Treatment of tachycardiac arrhythmias and arterial hypertension with verapamil].

1970 • 12 citations

Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol.

1984 • 12 citations

The long-term management of hypertension with verapamil.

1982 • 12 citations

The effect of verapamil on cardiovascular and metabolic responses to exercise

1986 • 12 citations

Verapamil Potassium Cardioplegia and Cardiac Conduction

1985 • 12 citations

Verapamil pharmacokinetics and liver function in patients with cirrhosis.

1988 • 12 citations

Twice-daily verapamil for hypertension: A comparison with propranolol

1986 • 11 citations

Pharmacokinetics of Verapamil and Norverapamil in Patients with Hypertension: A Comparison of Oral Conventional and Sustained Release Formulations

1988 • 11 citations

Comparative study of the antihypertensive effect of verapamil and atenolol

1986 • 10 citations

Slow Channel Blockers

1983 • 10 citations

Improvement of the quantitative determination of verapamil in human plasma.

1979 • 10 citations

Hydrochlorothiazide is not additive to verapamil in treating essential hypertension

1989 • 10 citations

Electrophysiological effects of quinidine alone and of the combination quinidine‐verapamil on av conduction in humans

1983 • 10 citations

[The treatment of renal hypertension with verapamil in childhood (author's transl].

1977 • 10 citations

Verapamil withdrawal as a possible cause of myocardial infarction in a hypertensive woman with a normal coronary angiogram

1988 • 9 citations

CALCIUM ANTAGONISTS AND HYPERTENSION

1988 • 9 citations

Nebulised sodium cromoglycate and verapamil in methacholine induced asthma.

1987 • 9 citations

Calcium antagonists and beta blockers in the control of mild to moderate systemic hypertension, with particular reference to verapamil and propranolol

1986 • 9 citations

Nicardipine and verapamil in essential hypertension

1986 • 9 citations

Intrauterine conversion of fetal supraventricular tachycardia with combination of digoxin and verapamil.

1985 • 9 citations

Relationships between verapamil plasma concentrations and its antihypertensive action.

1988 • 8 citations

Accentuated negative inotropism of verapamil after ischaemic intervention in isolated working rat heart

1984 • 8 citations

Sustained release verapamil in hypertension. Results from a noninvasive ambulatory blood pressure monitoring and a clinical study

1986 • 8 citations

Steady-state cerebrospinal fluid transfer of verapamil and metabolites in patients with schizophrenia

1988 • 8 citations

[Arterial hypotensive effect of verapamil in severe pre-eclampsia. Preliminary study].

1979 • 8 citations

A new sustained-release formulation of verapamil in the treatment of hypertension.

1986 • 8 citations

Celiprolol and verapamil in the treatment of essential hypertension

1988 • 8 citations

Effects of verapamil on estimated hepatic blood flow in patients with HBsAg-positive cirrhosis.

1988 • 8 citations

[Controlled study on the treatment of hypertension with verapamil in retard form].

1985 • 7 citations

Hemodynamic effects of verapamil in left ventricular valvular volume overload

1985 • 7 citations

Verapamil and supraventricular tachyarrhythmias: beneficial effect in patients with chronic pulmonary disease.

1980 • 7 citations

Nachweis von Verapamil¹im mütterlichen und fetalen Blut des Menschen²

1980 • 7 citations

Verapamil Sustained-Release in Renal Parenchymal Hypertension

1989 • 7 citations

Casual versus 24-hour ambulatory blood pressure recording in the evaluation of chronic administration of sustained-release verapamil.

1988 • 7 citations

Effects of quinidine, verapamil and nifedipine on the pharmacokinetics and pharmacodynamics of digitoxin during steady state conditions.

1987 • 7 citations

Efficacy of verapamil in patients resistant to other antihypertensive therapy

1986 • 6 citations

Electropharmacology of the Slow‐Channel Inhihitors in the Management of Cardiac Arrhythmias: Verapamil

1982 • 6 citations

The combination of verapamil and captopril in the treatment of essential hypertension.

1987 • 6 citations

Verapamil in Essential Hypertension: A Comparison with Atenolol Plus Hydralazine

1987 • 5 citations

Calcium Metabolism in Essential Hypertensive Patients Treated by Verapamil

1986 • 5 citations

Effect of Nifedipine and Verapamil on Carbohydrate Metabolism in Hypertensive Patients with Impaired Glucose Tolerance

1987 • 5 citations

Effects of verapamil on exocrine pancreatic secretion in man

1985 • 5 citations

Verapamil in hypertension--a long term study.

1982 • 5 citations

Clinical pharmacology of verapamil.

1988 • 5 citations

Effects of Sustained-Release Verapamil on 24-Hour Ambulatory Blood Pressure and on Pressor Response to Isometric Exertion in Hypertensive Patients

1989 • 5 citations

Flurbiprofen sustained-release in OA knee.

1988 • 5 citations

The Effects of Age on the Pharmacodynamics and Pharmacokinetics of Two Formulations of Verapamil

1989 • 5 citations

Diuretics and calcium antagonists in hypertension.

1988 • 5 citations

Effect of verapamil on glucose, insulin and glucagon levels after oral glucose load in normal and diabetic subjects.

1982 • 5 citations

A multicenter study of verapamil in systemic hypertension in Thailand

1986 • 4 citations

Verapamil-induced changes in digoxin kinetics in cirrhosis

1987 • 4 citations

Comparison of sustained release verapamil and hydrochlorothiazide in hypertension--effect on blood pressure and metabolic variables.

1987 • 4 citations

Abrupt withdrawal of verapamil in ischaemic heart disease. The Danish Study Group on Verapamil in Myocardial Infarction.

1984 • 4 citations

Antihypertensive efficacy of sustained-release verapamil.

1987 • 4 citations

Calcium Metabolism, Calcium-Channel Blocking Agents, and Hypertension Management

1988 • 4 citations

[Pharmacokinetics and pharmacodynamics of verapamil in healthy volunteers after single oral and sublingual administration].

1982 • 4 citations

Verapamil and Prazosin in Essential Hypertension

1987 • 4 citations

The Antihypertensive Effect of Verapamil in Twice and Thrice Daily Dose Regimens. A Randomized, Double-Blind, Crossover Trial

1983 • 4 citations

A Double-Blind, Randomized, Crossover Comparison of Equivalent (by Weight) Oral Doses of Verapamil and Diltiazem in Patients with Mild to Moderate Hypertension

1989 • 4 citations

Hypertension with Orthostatic Hypotension

1987 • 4 citations

Use of Verapamil for Paroxysmal Supraventricular Tachycardia During Epidural Anesthesia for Cesarean Section

1988 • 4 citations

Plasma lipid profile in verapamil-treated hypertensive patients.

1987 • 3 citations

Parenteral-Verapamil-Induced Sustained Hypotension

1984 • 3 citations

[Efficacy of verapamil in the prevention of ventricular fibrillation in the acute phase of myocardial infarction].

1988 • 3 citations

Calcium antagonists and hormone release. VI. Effects of a calcium antagonist (verapamil) on the biphasic insulin release in vivo.

1988 • 3 citations

[Electrophysiological effects of nicardipine hydrochloride (YC-93) on the human cardiac condition system].

1983 • 3 citations

Effect of sustained-release verapamil therapy on the blood pressure at rest and on the pressor response to isometric exertion in hypertensive patients

1988 • 3 citations

Tachyphylaxis to Verapamil

1986 • 3 citations

Efficacy of verapamil--hydrochlorothiazide-spironolactone therapy in hypertensive black patients.

1987 • 3 citations

Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.

1988 • 3 citations

Verapamil and beta-blockers in hypertension: a beneficial drug interaction?

1985 • 3 citations

Verapamil overdose.

1984 • 3 citations

Pharmacokinetics of once-daily verapamil: comparative bioavailability of two sustained-release formulations.

1988 • 3 citations

[Antihypertensive action of verapamil. Results with a new delayed-action form for once-daily administration].

1985 • 3 citations

Studies with sustained-release verapamil in essential hypertension.

1988 • 2 citations

Long-term safety and efficacy comparison of immediate-release and sustained-release oral verapamil in systemic hypertension.

1987 • 2 citations

Verapamil in the long-term treatment of angina pectoris.

1982 • 2 citations

Verapamil-potassium cardioplegia: a two-year experience with 470 patients.

1986 • 2 citations

Verapamil-neostigmine interaction?

1986 • 1 citations

Twenty-four-hour blood pressure monitoring after a single dose of sustained-release verapamil

1988 • 1 citations

Anglotensin Converting Enzyme Inhibitor, Diuretic, and Calcium Antagonist

1985 • 1 citations

Influence of verapamil and oxygen on pulmonary hypertension and right ventricular function.

1988 • 1 citations

Verapamil SR 240 mg as a contribution to compliance in long-term treatment of hypertension.

1987 • 1 citations

Calcium entry blockers and human platelet aggregation.

1988 • 1 citations

Treatment of Resistant Hypertension

1989 • 1 citations